Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2015: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2014: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Outline of Final Research Achievements |
For the purpose of stomach epithelium-specific gene modification, we newly generated Tff1-Cre mouse lines using the BAC transgenic technique. To elucidate the site of Tff1-Cre transgene expression, we crossed Tff1-Cre mice to Rosa-EYFP reporter mice, and analyzed the tissues with immunohistochemistry. Tff1-Cre positive cells were detected not only in pit and pre-pit cells but also in part of neck and chief cells. Tff1-Cre expression was not detected in parietal cells or endocrine cells. Next we crossed Tff1-Cre mice to LSL-KrasG12D mice. Tff1-Cre; LSL-KrasG12D mice displayed foveolar hyperplasia, oxyntic atrophy, and Alcian blue-positive mucous metaplasia at the age of 3 months. Now we are planning to cross Tff1-Cre mice to several other genetically modified mouse lines in order to study the mechanisms of gastric metaplasia and carcinogenesis.
|